[Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin]
[Article in
Spanish]
Affiliations
- PMID: 6100970
Item in Clipboard
[Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin]
[Article in
Spanish]
Rev Esp Oncol.
1983.
Abstract
Twenty three patients with small non oat-cell lung cancer were treated with a combination of cyclophosphamide, adriamycin and cisplatin chemotherapy. The treatment produced 30.4 per 100 objective responses (7 cases), with complete remission in 2 cases and partial remission in 5 cases. The remission duration was 7.5 and 6 months respectively. The initial "status performans" is important for the response.
Similar articles
-
Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.Cancer Treat Rep. 1984 Sep;68(9):1159-61. Cancer Treat Rep. 1984. PMID: 6090015
-
A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302. Cancer J Sci Am. 1997. PMID: 9327154
-
Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.J Chemother. 1989 Jul;1(4 Suppl):1205-6. J Chemother. 1989. PMID: 16312835 No abstract available.
-
[Treatment of lung cancer--state of the art in 2000].Gan To Kagaku Ryoho. 2000 Jul;27(8):1247-52. Gan To Kagaku Ryoho. 2000. PMID: 10945023 Review. Japanese.
-
[Postoperative adjuvant treatment for non-small cell lung cancer].Gan To Kagaku Ryoho. 2002 Dec;29(13):2470-4. Gan To Kagaku Ryoho. 2002. PMID: 12506468 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical